Echo45 Advisors LLC Merck & Co., Inc. Transaction History

Echo45 Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$123.8 - $132.96 $25,750 - $27,655	-208 Reduced 10.63%	1,748 $216,000
Q1 2024 Apr 18, 2024	SELL	$113.24 - $131.95 $4,529 - $5,278	-40 Reduced 2.0%	1,956 $258,000
Q4 2023 Jan 31, 2024	BUY	$100.18 - $109.02 $199,959 - $217,603	1,996 New	1,996 $217,000
Q2 2023 Jul 31, 2023	SELL	$108.61 - $118.38 $22,265 - $24,267	-205 Reduced 9.32%	1,994 $230,000
Q1 2023 Apr 26, 2023	SELL	$102.94 - $114.86 $10,808 - $12,060	-105 Reduced 4.56%	2,199 $233,000
Q4 2022 Jan 30, 2023	BUY	$87.44 - $112.11 $201,461 - $258,301	2,304 New	2,304 $255,000
Q2 2022 Jul 27, 2022	SELL	$83.49 - $94.64 $68,879 - $78,078	-825 Reduced 26.48%	2,290 $209,000
Q1 2022 Apr 29, 2022	SELL	$73.51 - $82.4 $47,266 - $52,983	-643 Reduced 17.11%	3,115 $256,000
Q4 2021 Feb 28, 2022	BUY	$72.28 - $90.54 $271,628 - $340,249	3,758 New	3,758 $288,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Echo45 Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Echo45 Advisors LLC with notifications on news.